Table 2 Adverse effects associated with amikacin
Adverse effects | N (%) |
|---|---|
Ototoxicity | |
 Subjective symptoms | 43/107 (40.2%) |
 Hearing impairment seen in audiograms | 30/77 (39.0%) |
 Nephrotoxicity | 6/96 (6.2%) |
 Vestibular toxicity | 4/107 (3.7%) |
PICC related complications | |
 Venous thromboembolism | 7/107 (6.5%) |
 Bloodstream infection | 1/107 (0.9%) |
 Fatigue | 6/107 (5.6%) |
 Skin rash | 5/107 (4.7%) |
 Paresthesias | 1/107 (0.9%) |
 Restless extremities | 1/107 (0.9%) |